Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade Gliomas

被引:74
作者
Tripathi, Madhavi [1 ]
Sharma, Rajnish [1 ]
D'Souza, Maria [1 ]
Jaimini, Abhinav [1 ]
Panwar, Puia [2 ]
Varshney, Raunak [2 ]
Datta, Anupama [2 ]
Kumar, Nitin [2 ]
Garg, Gunjan [1 ]
Singh, Dinesh [1 ]
Grover, Rajesh K. [3 ]
Mishra, Anil K. [2 ]
Mondal, Anupam [1 ]
机构
[1] Inst Nucl Med & Allied Sci, MIRC, Div PET Imaging, Delhi 110054, India
[2] Inst Nucl Med & Allied Sci, MIRC, Div Cyclotron & Radiopharmaceut Sci, Delhi 110054, India
[3] GTB Hosp, Delhi State Canc Inst, Div Med Oncol, Delhi, India
关键词
F-18-FDOPA; F-18; FLT; FDG; PET/CT; low grade gliomas; BRAIN-TUMORS; PROLIFERATION; REEVALUATION;
D O I
10.1097/RLU.0b013e3181becfe0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: We undertook this prospective study to compare amino acid metabolism, glucose metabolism, and proliferation in primary and recurrent low grade gliomas using positron emission tomography (PET)/computed tomography with F-18 FDOPA, F-18 FDG, and F-18 FLT. Methods: Fifteen patients with newly diagnosed or previously treated low grade gliomas (WHO grade I or II) were subjected to F-18-FDOPA, F-18 FDG, and F-18 FLT PET/computed tomography studies on consecutive days. This included 2 patients in remission as control subjects. Uptake of all the 3 tracers were analyzed visually and quantified using standardized uptake values and tumor to normal (T/N) ratios. The accuracy of all the 3 PET tracers in the detection of newly diagnosed and recurrent low grade gliomas was compared. Results: F-18 FDOPA was positive in all cases of primary and recurrent low grade gliomas and negative in the patients in remission. Tumor was visualized on F-18 FDG in 7 of 13 cases, F-18-FLT was positive in 4 of 13 cases. Average tumor standardized uptake values max for F-18 FDOPA (5.75 +/- 4.9) and F-18 FLT (1.8 +/- 0.91) was lower than that of F-18 FDG (8.5 +/- 4.4). TIN ratios for F-18-FDOPA (2.3 +/- 0.51) and F-18 FLT (1.8 +/- 0.91) were higher than F-18 FDG (1.03 +/- 0.64) providing good image contrast for tumor detection in positive cases. Conclusion: F-18 FDOPA scan is superior to both F-18 FLT and F-18 FDG for visualization of primary and recurrent low grade gliomas. F-18-FLT should not be considered for evaluation of recurrent low grade gliomas.
引用
收藏
页码:878 / 883
页数:6
相关论文
共 17 条
  • [1] Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine
    Becherer, A
    Karanikas, G
    Szabó, M
    Zettinig, G
    Asenbaum, S
    Marosi, C
    Henk, C
    Wunderbaldinger, P
    Czech, T
    Wadsak, W
    Kletter, K
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) : 1561 - 1567
  • [2] Chen W, 2005, J NUCL MED, V46, P945
  • [3] Chen W, 2006, J NUCL MED, V47, P904
  • [4] 11C-methionine PET for differential diagnosis of low-grade gliomas
    Herholz, K
    Hölzer, T
    Bauer, B
    Schröder, R
    Voges, J
    Ernestus, RI
    Mendoza, G
    Weber-Luxenburger, G
    Löttgen, J
    Thiel, A
    Wienhard, K
    Heiss, WD
    [J]. NEUROLOGY, 1998, 50 (05) : 1316 - 1322
  • [5] ISHIWATA K, 1993, J NUCL MED, V34, P1936
  • [6] Jager PL, 2001, J NUCL MED, V42, P432
  • [7] 18F-FDG and 18F-FET uptake in experimental soft tissue infection
    Kaim, AH
    Weber, B
    Kurrer, MO
    Westera, G
    Schweitzer, A
    Gottschalk, J
    von Schulthess, GK
    Buck, A
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (05) : 648 - 654
  • [8] THE USE OF PET IN EVALUATING PATIENTS WITH PRIMARY BRAIN-TUMORS - IS IT USEFUL
    OLIVERO, WC
    DULEBOHN, SC
    LISTER, JR
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (02) : 250 - 252
  • [9] Prediction of pathology and survival by FDG PET in gliomas
    Padma, MV
    Said, S
    Jacobs, M
    Hwang, DR
    Dunigan, K
    Satter, M
    Christian, B
    Ruppert, J
    Bernstein, T
    Kraus, G
    Mantil, JC
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2003, 64 (03) : 227 - 237
  • [10] Rasey JS, 2002, J NUCL MED, V43, P1210